跳至主要内容
临床试验/NCT02945293
NCT02945293Unknown不适用

Cognitive, Behavioral and Aging Effects of Pain Medication in Alcohol Users

University of Washington1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2015年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
128
试验地点
1
主要终点
response to a pain stimulus

研究概览

简要总结

The purpose of this study is to examine the relationship between heavy alcohol use, pain, and response to pain medication in older adults.

详细描述

Potential participants complete a phone screen. If still found eligible, the participant comes in for 1 screening visit (3 hours long). Cognitive/problem solving tests, computerized tasks, CPT, questionnaires and functional measures are administered along with a screening blood lab. If a participant is eligible, he/she comes back for 1 full study day visit (9-10 hours long). A testing battery (similar to the one done during the screening visit) is completed at baseline and again at three timepoints following medication administration. Blood draws, vital signs, and pupil measurements are taken throughout the day. A follow-up phone call is completed within a few days of the full study day visit, during which a questionnaire is given.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age of 35 years old or above
  • Mild to moderate pain
  • alcohol consumption
  • willingness to refrain from taking any sort of pain medication 24 hours prior to study visit as well as refraining from taking sedative-hypnotics, antihistamines, benzodiazepines, sleep aids, NSAIDs/opioid pain medications, alcohol, marijuana
  • Cigarette smokers must be willing to refrain from smoking during the all day study visit

排除标准

  • current regular use of an opioid or medications that involve the opioid receptor (naltrexone (vivitrol), buprenorphine (subutex), methadone (dolophine)
  • abstains from alcohol
  • unstable angina or CHF; cerebral vascular accident or recurrent TIAs in the prior 6 months, active cancer requiring current treatment, possible or probable dementia or mild cognitive impairment
  • Diagnosis of schizophrenia or schizoaffective disorder, or anxiety disorder requiring regular medication
  • History of recreational drug use in the past 1 year, excluding marijuana
  • New or increased dose (within last 6 months) of CNS-active medications that may alter neurocognitive and/or psychomotor function: MAO inhibitors, neuroleptics, antidepressants, anticonvulsants, benzodiazepines, sleep aids
  • Medications that may alter oxycodone metabolism: St. John's wort, Dilantin, tegretol, corticosteroids, rifampin
  • Known hypersensitivity to oxycodone and other opioids;
  • Pregnancy

结局指标

主要结局

response to a pain stimulus

时间窗: given during study day

Exposure to cold water, followed by exposure to warm water

次要结局

  • medication impact , opioid adjective checklist(Study day visit (9-10 hours long))
  • Pupil size(Study day visit (9-10 hours long))
  • functional measure of balance modified berg balance test(Screening visit (3 hours long) and study day visit (9-10 hours long))
  • verbal memory performance on list learning task(Study day visit (9-10 hours long))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Monique Cherrier

Associate Professor, School of Medicine: Psychiatry And Behavioral Sciences

University of Washington

研究点 (1)

Loading locations...

相似试验

Cognitive, Behavioral and Aging Effects of Pain... | 临床试验